I'm LongbridgeAI, I can summarize articles.MarketBeat's stock screener highlights five healthcare stocks to watch: Alphabet, UnitedHealth Group, Hims & Hers Health, Centene, and Thermo Fisher Scientific. These companies are noted for their significant trading volumes and potential growth driven by demographic trends and technological innovations. Alphabet's stock rose to $193.09, UnitedHealth Group reached $283.80, Hims & Hers Health traded at $58.45, and Centene's stock hit $28.12. Investors are advised to monitor these stocks due to their performance sensitivity to healthcare policies and market dynamics.
- 3 Stocks Flying Under the S&P 500 Radar
Alphabet, UnitedHealth Group, Hims & Hers Health, Centene, and Thermo Fisher Scientific are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are equity shares of publicly traded companies that develop, manufacture, or distribute medical products and services—ranging from pharmaceuticals and biotechnology firms to medical device makers and healthcare providers. Investors often view them as a defensive sector with growth potential driven by demographic trends, technological innovation and regulatory changes. Performance in this sector can be particularly sensitive to factors such as drug approvals, healthcare policy shifts and clinical trial outcomes. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
Alphabet (GOOGL)
Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube.
- Congress Is Dumping These 5 Stocks—Should You Follow?
GOOGL stock traded up $0.92 during trading on Friday, hitting $193.09. The company had a trading volume of 24,133,082 shares, compared to its average volume of 36,965,305. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The firm has a market cap of $2.34 trillion, a PE ratio of 20.58, a price-to-earnings-growth ratio of 1.33 and a beta of 1.00. The firm has a 50-day moving average price of $175.23 and a 200-day moving average price of $173.10. Alphabet has a 1-year low of $140.53 and a 1-year high of $207.05.
Read Our Latest Research Report on GOOGL
UnitedHealth Group (UNH)
- Alphabet’s Breakout Quarter Signals a New Leadership Phase
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
UNH stock traded up $5.22 on Friday, reaching $283.80. 9,076,020 shares of the company's stock were exchanged, compared to its average volume of 11,304,793. The firm has a market cap of $257.45 billion, a PE ratio of 11.87, a P/E/G ratio of 1.45 and a beta of 0.45. UnitedHealth Group has a twelve month low of $248.88 and a twelve month high of $630.73. The stock has a fifty day moving average of $301.79 and a 200-day moving average of $427.21. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.
Read Our Latest Research Report on UNH
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Shares of HIMS traded up $1.13 during trading hours on Friday, reaching $58.45. 34,489,919 shares of the company traded hands, compared to its average volume of 33,692,676. Hims & Hers Health has a fifty-two week low of $13.47 and a fifty-two week high of $72.98. The stock has a market capitalization of $13.08 billion, a PE ratio of 84.12, a price-to-earnings-growth ratio of 2.14 and a beta of 2.02. The stock has a fifty day simple moving average of $53.29 and a 200 day simple moving average of $42.56.
Read Our Latest Research Report on HIMS
Centene (CNC)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Shares of CNC traded up $1.36 during trading hours on Friday, reaching $28.12. 46,050,345 shares of the company's stock traded hands, compared to its average volume of 7,553,626. The firm has a market capitalization of $13.99 billion, a price-to-earnings ratio of 4.18, a P/E/G ratio of 0.55 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.11 and a quick ratio of 1.11. The business's fifty day simple moving average is $47.43 and its two-hundred day simple moving average is $56.11. Centene has a twelve month low of $26.25 and a twelve month high of $80.59.
Read Our Latest Research Report on CNC
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Shares of TMO stock traded up $3.36 during mid-day trading on Friday, hitting $478.39. 2,496,699 shares of the stock traded hands, compared to its average volume of 2,499,708. The company's 50-day simple moving average is $412.43 and its 200-day simple moving average is $470.68. The firm has a market cap of $180.59 billion, a price-to-earnings ratio of 27.70, a price-to-earnings-growth ratio of 2.25 and a beta of 0.77. Thermo Fisher Scientific has a twelve month low of $385.46 and a twelve month high of $627.88. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.38 and a current ratio of 1.93.
Read Our Latest Research Report on TMO
Further Reading
- MarketBeat's Top Five Stocks to Own in July 2025
- ServiceNow: The 2nd Wave of AI Spending Is Here
- Tractor Supply Revs Up on Forecast Hike and Bullish Signals
- 3 Short Squeeze Candidates With Big Catalysts on the Horizon
- CrowdStrike Scores Big With Gartner, But Valuation Is Stretched
- Intel's Turnaround Gains Credibility With Strong Q2 Report
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Alphabet Right Now?
Before you consider Alphabet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alphabet wasn't on the list.
While Alphabet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
